VA Will Update Informed Consent Policies in 2027
Veterans prescribed specific psychotropic drugs will be required to sign new consent forms starting in 2027.
Updated on Sept. 29, 2026 in Mental Health

Live Poll
Do you believe stricter informed consent requirements for psychiatric medications will improve patient care?
The Department of Veterans Affairs announced new informed consent requirements for veterans prescribed certain psychotropic medications, which will go into effect in 2027. This initiative impacts a significant portion of the 4.5 million veterans currently receiving psychiatric prescriptions through the system.
Why it matters
The policy change aims to enhance patient transparency regarding the potential risks and benefits of specific psychiatric drugs. By mandating signature consent, the VA seeks to ensure veterans are more fully informed about their treatment plans for conditions like PTSD.
Official policy documentation confirms that 80% of veterans with PTSD currently receive psychiatric medications, informing the need for standardized consent protocols for the 4.5 million veterans using these drugs. This guidance is preliminary as it is scheduled for future implementation in 2027.
The players
Department of Veterans Affairs
The federal department responsible for providing healthcare services to U.S. military veterans.
President Donald Trump
The current President of the United States who issued an executive order regarding psychedelic drug access.
ARPA-H
An agency dedicated to high-impact health research that allocated $50 million for state-level psychedelic programs.
The details
The new guidelines mandate that veterans provide written signature consent before being prescribed antidepressants if they are younger than 30. Additionally, signature consent will be required prior to the concurrent prescription of opioids and benzodiazepines to mitigate risks associated with combining these specific medication classes.
Timeline
April 2026: President Donald Trump issued an executive order regarding psychedelic drug access.
September 28, 2026: The VA announced the new medication consent guidance.
2027: New informed consent guidance takes effect.
Health Landscape
These new requirements sit within a broader push to modernize mental health care for veterans, including the $50 million investment in psychedelic programs and 20 ongoing clinical trials. This reflects an evolving approach to psychiatric treatment that emphasizes both safety-focused regulation and experimental therapy.
If you are a veteran currently prescribed antidepressants or a combination of opioids and benzodiazepines, plan to discuss these upcoming consent requirements with your care team. It is worth consulting your physician now to understand how these future changes may affect your personal treatment plan.
The takeaway
The VA is prioritizing clearer communication for veterans regarding the risks of specific psychiatric and pain management medications. You can track this transition by requesting a review of your current prescriptions during your next scheduled appointment with a healthcare provider.
Further reading
For more information on current treatment standards, visit Mental Health.
Source note: This article includes information reported by Military.
Live Poll
Do you believe stricter informed consent requirements for psychiatric medications will improve patient care?










